| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |